Breast
cancer is one of the major diseases that threaten women’s health. Lymph node (LN) metastasis is the most common metastatic
path of breast cancer. Finding a simple, effective, and safe strategy
to eliminate metastatic tumors in LNs is highly desired for clinical
use. Carbon nanoparticles (CNs), as an LN tracer, have been widely
used in the clinical setting. In addition, previous experiments have
confirmed that CNs have good photoacoustic imaging and photothermal
effects. In this study, we used CNs as a photothermal conversion material
and drug carrier, poly(lactic-co-glycolic acid) (PLGA)
as a film-forming material, and docetaxel as a chemotherapy drug to
prepare multifunctional nanoparticles (DOC-CNPs). The prepared DOC-CNPs
present as a black solution, which shows smooth spherical particles
under light microscopy and transmission electron microscopy (TEM),
and they have a good ability for liquid–gas phase transition,
good dispersibility, high drug-loading capacity, and low cytotoxicity.
In vitro, they can release drugs and inhibit tumor cells after laser
irradiation. The photoacoustic (PA) signal intensity and the photothermal
conversion efficiency increased with an increase in the concentration
of DOC-CNPs. In vivo, after administration, the DOC-CNPs reached the
LNs. After laser irradiation, the DOC-CNPs absorbed laser energy,
and the temperature of the LNs increased high enough to achieve photothermal
therapy under PA and ultrasound monitoring. Fracture of the DOC-CNPs
was caused by the liquid–gas phase transition with the increased
temperature, and the ruptured DOC-CNPs released docetaxel to achieve
targeted chemotherapy. These findings suggested that DOC-CNPs can
achieve precise treatment for metastatic LNs of breast cancer with
PA and ultrasound visualization.